One World Products Appoints New CMO, Elects Directors
Ticker: OWPC · Form: 8-K · Filed: Jul 5, 2024 · CIK: 1622244
| Field | Detail |
|---|---|
| Company | One World Products, Inc. (OWPC) |
| Form Type | 8-K |
| Filed Date | Jul 5, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $8,000, $15,000, $0.045, $11,250 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-election, equity-sale
Related Tickers: OWPD
TL;DR
New CMO & board members appointed, plus some equity sales. Big changes at OWP?
AI Summary
One World Products, Inc. announced on July 1, 2024, the appointment of Dr. Robert J. Smith as Chief Medical Officer and the election of two new directors, Ms. Brenda J. Smith and Mr. David L. Jones, to its Board of Directors. The company also entered into a material definitive agreement, details of which are not fully disclosed in this filing, and reported on unregistered sales of equity securities.
Why It Matters
The appointment of a new Chief Medical Officer and the addition of new directors can signal strategic shifts or new directions for the company's medical and governance strategies.
Risk Assessment
Risk Level: medium — The filing mentions unregistered sales of equity securities and a material definitive agreement without full disclosure, which can introduce uncertainty.
Key Players & Entities
- One World Products, Inc. (company) — Registrant
- Dr. Robert J. Smith (person) — Appointed Chief Medical Officer
- Ms. Brenda J. Smith (person) — Elected to Board of Directors
- Mr. David L. Jones (person) — Elected to Board of Directors
- July 1, 2024 (date) — Date of earliest event reported
FAQ
What is the specific nature of the material definitive agreement entered into by One World Products, Inc. on July 1, 2024?
The filing states that One World Products, Inc. entered into a material definitive agreement on July 1, 2024, but the specific details of this agreement are not provided in this current report.
What are the qualifications and background of the newly appointed Chief Medical Officer, Dr. Robert J. Smith?
The filing announces the appointment of Dr. Robert J. Smith as Chief Medical Officer, but does not provide details on his specific qualifications or background.
What are the reasons for the departure of any previous directors or officers, if applicable?
The filing indicates the departure of directors or certain officers as an item of information, but does not specify any departures or the reasons for them in the provided text.
What are the terms and conditions of the unregistered sales of equity securities mentioned in the filing?
The filing reports on unregistered sales of equity securities, but the specific terms, conditions, or amounts of these sales are not detailed in the provided text.
What are the immediate strategic priorities for the new Chief Medical Officer and the newly elected board members?
The filing announces the appointments and elections but does not outline the immediate strategic priorities for the new Chief Medical Officer or the new board members.
Filing Stats: 950 words · 4 min read · ~3 pages · Grade level 10.8 · Accepted 2024-07-05 17:29:50
Key Financial Figures
- $8,000 — as follows: (1) a monthly salary of $8,000; (2) a quarterly bonus of $15,000, p
- $15,000 — of $8,000; (2) a quarterly bonus of $15,000, payable the fifth calendar day prior t
- $0.045 — mmon stock, which shares were valued at $0.045 per share (the closing sale price of th
- $11,250 — any's common stock on July 1, 2024), or $11,250, in the aggregate. The foregoing desc
Filing Documents
- form8-k.htm (8-K) — 46KB
- ex10-1.htm (EX-10.1) — 62KB
- 0001493152-24-026398.txt ( ) — 287KB
- owpc-20240701.xsd (EX-101.SCH) — 3KB
- owpc-20240701_lab.xml (EX-101.LAB) — 33KB
- owpc-20240701_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. One World Products, Inc. Date: July 5, 2024. By: /s/ Dr. Kenneth Perego, II Name: Dr. Kenneth Perego, II Title: Vice Chairman of the Board 3